In spite of this, substantial precaution needs to be given when combining IFN-γ with RT for therapeutic purpose, as an early phase IIIA/B clinical trial in patients with NSCLC reported severe toxicities including fatal radiation pneumonitis [56]. Here, IFNG is linked to non-small cell lung carcinoma.